Enabling Oral Delivery of Sensitive Molecules

July 09, 2015

Enteric capsule drug delivery technology (ECDDT) was developed to provide oral delivery with full enteric protection and rapid release in the GI tract without the use of coatings. ECDDT’s intrinsically enteric properties are attained by incorporating pharmaceutically approved enteric polymers in the capsule shell using conventional capsule manufacturing processes. By eliminating the need for enteric coating, ECDDT can enable the oral delivery of sensitive molecules, such as nucleotides and peptides, biological products such as vaccines, and live biotherapeutic products (LBPs), which can degrade at the high temperatures or can be sensitive to aqueous coating solution associated with coating processes.


  • Hassan Benameur, Ph.D.
Register Now